AstraZeneca Partly Resumes Coronavirus Vaccine Trial After Halting It for Safety

The pharmaceutical company AstraZeneca said Saturday that it had resumed its coronavirus vaccine trial in Britain after suspending it six days ago over potential safety issues but that its trials in the United States and other countries were still on hold.

The news came the same day that a competitor, Pfizer, said it was expanding the trial of its coronavirus vaccine to 44,000 people — a big increase from its previous goal of 30,000 — in an effort to recruit a more diverse group of…

Read Full Article

LEAVE A REPLY

Please enter your comment!
Please enter your name here